The landscape of medical artificial intelligence (AI) is experiencing unprecedented momentum. Since January, 2023, the number ...

The COMPASSION-16 trial by Xiaohua Wu and colleagues addresses a crucial need in the management of advanced cervical cancer by evaluating cadonilimab, a novel bispecific antibody targeting PD-1 and ...